4//SEC Filing
Cuillerot Jean-Marie 4
Accession 0000905148-24-000183
CIK 0001781174other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:45 PM ET
Size
5.2 KB
Accession
0000905148-24-000183
Insider Transaction Report
Form 4
Cuillerot Jean-Marie
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-11+99,300→ 99,300 totalExercise: $4.82Exp: 2034-01-10→ Common Stock (99,300 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2025, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001696108
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:45 PM ET
- Size
- 5.2 KB